Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

This study has been completed.
Information provided by Antigenics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Malignant Melanoma
2		Additional conditions recognized in this trial
			Melanoma
3		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Nerve Tissue
			Neuroectodermal Tumors
			Neuroendocrine Tumors
			Nevi and Melanomas
4		Interventions listed in this trial
			HSPPC-96 or Oncophage
5		Sponsors listed in this trial
			Antigenics